Glmd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Glmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Glmd Today - Breaking & Trending Today

StockNews.com Initiates Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)

Research analysts at StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD remained flat at $0.39 during trading on Thursday. The company had a […] ....

Galmed Pharmaceuticals Stock Performance , Galmed Pharmaceuticals , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals Ltd , Get Free Report , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance NASDAQ GLMD opened at $0.39 on Wednesday. Galmed Pharmaceuticals has a one year low of $0.26 and a one year high of […] ....

Galmed Pharmaceuticals Stock Performance , Galmed Pharmaceuticals Ltd , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals , Free Report , Get Free Report , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Trading Down 1.6 % Shares of GLMD opened at $0.31 on Friday. Galmed Pharmaceuticals has a 12 month […] ....

United Kingdom , Galmed Pharmaceuticals Ltd , Galmed Pharmaceuticals , News Ratings For Galmed Pharmaceuticals Daily , Walleye Capital , Millennium Management , Cambridge Investment Research Advisors Inc , Raymond James Financial Services Advisors Inc , Galmed Pharmaceuticals Trading Down , Institutional Trading Of Galmed Pharmaceuticals , Get Free Report , Pharmaceuticals Trading Down , James Financial Services Advisors , Cambridge Investment Research Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance NASDAQ:GLMD opened at $0.36 on Tuesday. The company’s 50 day moving average price is $0.40 and its 200-day moving average […] ....

United Kingdom , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals Ltd , Millennium Management , Raymond James Financial Services Advisors Inc , Walleye Capital , Institutional Trading Of Galmed Pharmaceuticals , Galmed Pharmaceuticals , Cambridge Investment Research Advisors Inc , Galmed Pharmaceuticals Price Performance , Galmed Pharmaceuticals Company Profile , Free Report , Get Free Report , James Financial Services Advisors , Cambridge Investment Research Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Short Interest Update

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 11,500 shares, a decline of 79.1% from the January 15th total of 55,100 shares. Based on an average daily volume of 185,500 shares, the short-interest ratio […] ....

United Kingdom , Cambridge Investment Research Advisors Inc , Hedge Funds Weigh In On Galmed Pharmaceuticals , Walleye Capital , Galmed Pharmaceuticals Ltd , Galmed Pharmaceuticals Company Profile , Raymond James Financial Services Advisors Inc , Millennium Management , Galmed Pharmaceuticals Trading , Galmed Pharmaceuticals , News Ratings For Galmed Pharmaceuticals Daily , Get Free Report , Investment Research Advisors , James Financial Services Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd ,